MOTS-C in Dubai: The Mitochondrial Peptide Studied for Metabolic Health and Exercise Adaptation
MOTS-C is a mitochondrially-derived peptide discovered in 2015. Here is what the research says about its role in metabolic regulation and how independent physicians approach it in the UAE.
By UAE Peptide Clinic
What is MOTS-C?
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a microprotein encoded within the mitochondrial genome, making it one of the very few known peptides to originate from mitochondrial DNA rather than nuclear DNA. Discovered in 2015 by researchers at the University of Southern California, it has attracted significant scientific interest for its potential role in metabolic regulation, insulin sensitivity, and exercise-related cellular signalling. In the UAE, it can only be prescribed by a licensed physician.
Why is MOTS-C significant?
The significance of MOTS-C lies in its origin and mechanism. As a mitochondrially-derived peptide, it represents a relatively new category of biological signalling molecule — one that appears to communicate between mitochondria and other cellular systems. Preclinical research has examined MOTS-C in the context of AMPK pathway activation, glucose metabolism, fat oxidation, and exercise performance. These mechanisms have made it a compelling area of research in longevity and metabolic medicine.
MOTS-C and metabolic health in Dubai
Dubai's population includes a large and active community of fitness-focused individuals, athletes, and health-conscious professionals who follow developments in preventive medicine closely. MOTS-C has drawn interest from this audience because of research into its links with metabolic efficiency, insulin sensitivity, and exercise adaptation. Through UAE Peptide Clinic, any decision about MOTS-C is made individually by an independent DHA-licensed physician after reviewing metabolic health markers.
How MOTS-C is prescribed in the UAE
Where an independent physician considers MOTS-C appropriate, the dose, frequency and duration are set by that physician; published research has not established standardised human dosing. MOTS-C is sometimes discussed alongside NAD+, as both relate to mitochondrial function through different pathways, and any combination requires physician review.
How the process works
The process begins with a physician consultation through UAE Peptide Clinic. An independent DHA-licensed physician reviews metabolic health, goals, and health history before deciding whether a prescription is appropriate. Where prescribed, MOTS-C is dispensed as pharmacy-grade vials by a licensed compounding pharmacy and cold-chain delivered across Dubai, Abu Dhabi, Sharjah, and all UAE emirates, typically within 3 to 5 business days of the prescription.
- Prescription required, following a consultation with an independent DHA-licensed physician
- Dose, frequency and duration are set by the prescribing physician
- Sometimes discussed alongside NAD+ in mitochondrial research
- Physician reviews metabolic health markers before any prescription
- Cold-chain delivery to all UAE emirates
Whether any protocol is appropriate is a decision for an independent DHA-licensed physician. Read more on the MOTS-C page.
If you want to understand whether any of this is relevant to you, an independent DHA-licensed physician can review your case. Take the two-minute quiz at /find-my-stack or book a physician consultation at /book (AED 300 deposit, credited to your first order).
